Russia's largest pharmaceutical company to buy Singapore-based API supplier for $590 million
06:31 AM | August 19, 2013 | Deepti Ramesh
Pharmstandard (Moscow), Russia's leading pharmaceutical company, says it will acquire Bever Pharmaceutical (Singapore), a supplier of active pharmaceutical ingredients (APIs), for a total of $590...
This information is only available to subscribers.
chemweek.com is the one stop platform for chemical news, data and analysis across all industry sectors and geographies.